Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 15;7(11):e016221.
doi: 10.1136/bmjopen-2017-016221.

Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study

Affiliations

Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study

Thomas Cars et al. BMJ Open. .

Abstract

Objectives: To investigate if use of antibiotics was associated with bacterial complications following upper respiratory tract infections (URTIs).

Design: Ecological time-trend analysis and a prospective cohort study.

Setting: Primary, outpatient specialist and inpatient care in Stockholm County, Sweden. All analyses were based on administrative healthcare data on consultations, diagnoses and dispensed antibiotics from January 2006 to January 2016.

Main outcome measures: Ecological time-trend analysis: 10-year trend analyses of the incidence of URTIs, bacterial infections/complications and respiratory antibiotic use. Prospective cohort study: Incidence of bacterial complications following URTIs in antibiotic-exposed and non-exposed patients.

Results: The utilisation of respiratory tract antibiotics decreased by 22% from 2006 to 2015, but no increased trend for mastoiditis (p=0.0933), peritonsillar abscess (p=0.0544), invasive group A streptococcal disease (p=0.3991), orbital abscess (p=0.9637), extradural and subdural abscesses (p=0.4790) and pansinusitis (p=0.3971) was observed. For meningitis and acute ethmoidal sinusitis, a decrease in the numbers of infections from 2006 to 2015 was observed (p=0.0038 and p=0.0003, respectively), and for retropharyngeal and parapharyngeal abscesses, an increase was observed (p=0.0214). Bacterial complications following URTIs were uncommon in both antibiotic-exposed (less than 1.5 per 10 000 episodes) and non-exposed patients (less than 1.3 per 10 000 episodes) with the exception of peritonsillar abscess after tonsillitis (risk per 10 000 tonsillitis episodes: 32.4 and 41.1 in patients with no antibiotic treatment and patients treated with antibiotics, respectively).

Conclusions: Bacterial complications following URTIs are rare, and antibiotics may lack protective effect in preventing bacterial complications. Analyses of routinely collected administrative healthcare data can provide valuable information on the number of URTIs, antibiotic use and bacterial complications to patients, prescribers and policy-makers.

Keywords: epidemiology; infection control.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Definition of an episode of upper respiratory tract infection (here exemplified with acute otitis media (AOM)).
Figure 2
Figure 2
Trend for respiratory tract antibiotic utilisation in Stockholm County from 2006 to 2015. DDD, defined daily dose.
Figure 3
Figure 3
Trend for bacterial complications in Stockholm County from 2006 to 2015.

References

    1. Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278–82. 10.3201/eid0803.010192 - DOI - PMC - PubMed
    1. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579–87. 10.1016/S0140-6736(05)70799-6 - DOI - PubMed
    1. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096 10.1136/bmj.c2096 - DOI - PubMed
    1. Kaplan W, Wirtz V, Mantel-Teeuwisse A, et al. Priority mnedicines for Europe and the World 2013 update. Geneva: World Health Organization in collaboration with Utrecht University and Boston University, 2013.
    1. Adriaenssens N, Coenen S, Versporten A, et al. ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011;66(Suppl 6):vi3–12. 10.1093/jac/dkr453 - DOI - PubMed

Substances